CENTER FOR BIOMOLECULAR

Jinyoung Park Senior Researcher

Phone

02-958-5071

E-mail

jypark@kist.re.kr

Office

–

Homepage

–

EDUCATION

  • 02 Genetic Engineering, Sungkyunkwan Univ. (B.S)
  • 02 School of Medicine, Sungkyunkwan Univ. (M.S)
  • 02 School of Medicine, Sungkyunkwan Univ. (Ph.D)

CAREER

  • 03~2018.07 Postdoctoral fellow, Molecular Recognition Research Center, KIST
  • 08~2020.02 Research scientist, Molecular Recognition Research Center, KIST
  • 03~ Senior research scientist, Molecular Recognition Research Center, KIST
  • 03~ Committee member, Women’s Bioscience Forum

RESEARCH INTERESTS

  • Function and mechanism of Deubiquitinating enzymes in cancer
  • Protein degradation via ubiquitin-proteasome system
  • Transcriptional regulation of liver/fat metabolism

HIGHLIGHT

– papers

  • Park J, Cho J, Song EJ. (2020). Ubiquitin-proteasome system (UPS) as a target for anticancer treatment. Arch Pharm Res. 1-18.
  • Cho J*, Park J*, Kim EE, Song EJ. (2020). Assay Systems for Profiling Deubiquitinating Activity. Int J Mol Sci. 21(16):5638.
  • Cho J, Park J, Shin SC, Jang M, Kim JH, Kim EE, Song EJ. (2020). USP47 Promotes Tumorigenesis by Negative Regulation of p53 through Deubiquitinating Ribosomal Protein S2. Cancers. 12(5):1137.
  • Chae DK*, Park J*, Cho M, Ban E, Jang M, Yoo YS, Kim EE, Baik JH, Song EJ. (2019). MiR-195 and miR-497 suppress tumorigenesis and metastasis in lung cancer by inhibiting SMURF2-induced TGF-β receptor 1 ubiquitination. Mol Oncol. doi: 10.1002/1878-0261.
  • Park J, Kwon MS, Kim E, Lee H, Song EJ. (2018). USP35 Regulates Mitotic Progression by Modulating the Stability of Aurora B. Nat Commun. 15;9(1):688.

– patents

  • Screening method for lung cancer treatment agent using miR-195 or miR-497. 10-2190910
  • Methods for increasing the detection efficiency of trace amounts of miRNA in the blood. 10-2205620